TD Cowen analyst Charles Rhyee raised the firm’s price target on CVS Health (CVS) to $80 from $73 and keeps a Buy rating on ...

Fintel reports that on November 25, 2024, TD Cowen upgraded their outlook for Sally Beauty Holdings (NYSE:SBH) from Hold to ...

Fintel reports that on November 25, 2024, TD Cowen downgraded their outlook for Despegar.com (NYSE:DESP) from Buy to Sell.

We recently compiled a list of the 10 Trending AI Stocks Making Waves Today. In this article, we are going to take a look at ...

We recently compiled a list of the 15 AI News Shaping Wall Street Today. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Trending AI Stocks Making Waves Today. In this article, we are going to take a look at ...

TD Cowen analyst Derrick Wood maintained a Buy rating on Microsoft (MSFT – Research Report) today and set a price target of $475.00. The ...

TD Cowen says that in response to the legal action taken against the FDA by the Outsourcing Facilities Association on the removal of ...

MicroStrategy is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company said Monday that it bought about $5.4 billion of ...

On Friday, TD Cowen's Bryan Bergin slapped a new 12-month price target on Mastercard of $567 per share, well up from his ...

Investing.com -- The Federal Reserve’s semi-annual Supervision and Regulation report signals potential headwinds for the mergers and acquisitions (M&A) in 2025, according to TD Cowen. The report found ...

As reported by the Globe and Mail, TD analyst David Kwan November 22 launched coverage of VHI with a “Buy” rating and a ...